Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 302 (5642): 84-88

Copyright © 2003 by the American Association for the Advancement of Science

CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

Giovanni Marsicano,1* Sharon Goodenough,2,4* Krisztina Monory,1* Heike Hermann,1 Matthias Eder,3 Astrid Cannich,1 Shahnaz C. Azad,3,5 Maria Grazia Cascio,6 Silvia Ortega Gutiérrez,7 Mario van der Stelt,6 Maria Luz López-Rodríguez,7 Emilio Casanova,8 Günther Schütz,8 Walter Zieglgänsberger,3 Vincenzo Di Marzo,6 Christian Behl,2,4{dagger} Beat Lutz1{dagger}{ddagger}

Abstract: Abnormally high spiking activity can damage neurons. Signaling systems to protect neurons from the consequences of abnormal discharge activity have been postulated. We generated conditional mutant mice that lack expression of the cannabinoid receptor type 1 in principal forebrain neurons but not in adjacent inhibitory interneurons. In mutant mice,the excitotoxin kainic acid (KA) induced excessive seizures in vivo. The threshold to KA-induced neuronal excitation in vitro was severely reduced in hippocampal pyramidal neurons of mutants. KA administration rapidly raised hippocampal levels of anandamide and induced protective mechanisms in wild-type principal hippocampal neurons. These protective mechanisms could not be triggered in mutant mice. The endogenous cannabinoid system thus provides on-demand protection against acute excitotoxicity in central nervous system neurons.

1 Molecular Genetics of Behaviour, Max-Planck-Institute of Psychiatry, Kraepelinstraße 2-10, 80804 Munich, Germany.
2 Neurodegeneration, Max-Planck-Institute of Psychiatry, Kraepelinstraße 2-10, 80804 Munich, Germany.
3 Clinical Neuropharmacology Group, Max-Planck-Institute of Psychiatry, Kraepelinstraße 2-10, 80804 Munich, Germany.
4 Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg–University, Duesbergweg 6, 55099 Mainz, Germany.
5 Clinic of Anaesthesiology, LudwigMaximilians-University, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany.
6 Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli (Napoli), Italy.
7 Department of Organic Chemistry, Complutense University, 28040 Madrid, Spain.
8 Division of Molecular Biology of the Cell I, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.

Back to Top

* These authors contributed equally to this work.

{dagger} These authors share senior authorship.

{ddagger} To whom correspondence should be addressed. E-mail: lutz{at}mpipsykl.mpg.de


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
BDNF-endocannabinoid interactions at neocortical inhibitory synapses require phospholipase C signaling.
L. Zhao and E. S. Levine (2014)
J Neurophysiol 111, 1008-1015
   Abstract »    Full Text »    PDF »
Endocannabinoids in Synaptic Plasticity and Neuroprotection.
J.-Y. Xu and C. Chen (2014)
Neuroscientist
   Abstract »    Full Text »    PDF »
Cannabinoid CB1 Receptor in Dorsal Telencephalic Glutamatergic Neurons: Distinctive Sufficiency for Hippocampus-Dependent and Amygdala-Dependent Synaptic and Behavioral Functions.
S. Ruehle, F. Remmers, H. Romo-Parra, F. Massa, M. Wickert, S. Wortge, M. Haring, N. Kaiser, G. Marsicano, H.-C. Pape, et al. (2013)
J. Neurosci. 33, 10264-10277
   Abstract »    Full Text »    PDF »
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation.
E. Gaffal, M. Cron, N. Glodde, T. Bald, R. Kuner, A. Zimmer, B. Lutz, and T. Tuting (2013)
J. Immunol. 190, 4929-4936
   Abstract »    Full Text »    PDF »
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade.
L. Bellocchio, E. Soria-Gomez, C. Quarta, M. Metna-Laurent, P. Cardinal, E. Binder, A. Cannich, A. Delamarre, M. Haring, M. Martin-Fontecha, et al. (2013)
PNAS 110, 4786-4791
   Abstract »    Full Text »    PDF »
Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony.
C. Sales-Carbonell, P. E. Rueda-Orozco, E. Soria-Gomez, G. Buzsaki, G. Marsicano, and D. Robbe (2013)
PNAS 110, 719-724
   Abstract »    Full Text »    PDF »
Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor.
F. A. Pamplona, J. Ferreira, O. Menezes de Lima Jr., F. S. Duarte, A. F. Bento, S. Forner, J. G. Villarinho, L. Bellocchio, C. T. Wotjak, R. Lerner, et al. (2012)
PNAS 109, 21134-21139
   Abstract »    Full Text »    PDF »
Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development.
J. Diaz-Alonso, M. Guzman, and I. Galve-Roperh (2012)
Phil Trans R Soc B 367, 3229-3241
   Abstract »    Full Text »    PDF »
The endocannabinoid system in normal and pathological brain ageing.
A. Bilkei-Gorzo (2012)
Phil Trans R Soc B 367, 3326-3341
   Abstract »    Full Text »    PDF »
The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis.
J. Diaz-Alonso, T. Aguado, C.-S. Wu, J. Palazuelos, C. Hofmann, P. Garcez, F. Guillemot, H.-C. Lu, B. Lutz, M. Guzman, et al. (2012)
J. Neurosci. 32, 16651-16665
   Abstract »    Full Text »    PDF »
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity.
E. Butti, M. Bacigaluppi, S. Rossi, M. Cambiaghi, M. Bari, A. Cebrian Silla, E. Brambilla, A. Musella, R. De Ceglia, L. Teneud, et al. (2012)
Brain 135, 3320-3335
   Abstract »    Full Text »    PDF »
Endocannabinoid-dependent plasticity at spinal nociceptor synapses.
A. Kato, P. Punnakkal, A. J. Pernia-Andrade, C. von Schoultz, S. Sharopov, R. Nyilas, I. Katona, and H. U. Zeilhofer (2012)
J. Physiol. 590, 4717-4733
   Abstract »    Full Text »    PDF »
Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core.
W. Wang, D. Dever, J. Lowe, G. P. Storey, A. Bhansali, E. K. Eck, I. Nitulescu, J. Weimer, and N. S. Bamford (2012)
J. Physiol. 590, 3743-3769
   Abstract »    Full Text »    PDF »
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain.
L. Callen, E. Moreno, P. Barroso-Chinea, D. Moreno-Delgado, A. Cortes, J. Mallol, V. Casado, J. L. Lanciego, R. Franco, C. Lluis, et al. (2012)
J. Biol. Chem. 287, 20851-20865
   Abstract »    Full Text »    PDF »
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors.
M. Metna-Laurent, E. Soria-Gomez, D. Verrier, M. Conforzi, P. Jego, P. Lafenetre, and G. Marsicano (2012)
J. Neurosci. 32, 7109-7118
   Abstract »    Full Text »    PDF »
Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.
B. E. Alger (2012)
J. Physiol. 590, 2203-2212
   Abstract »    Full Text »    PDF »
Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor.
M. Pucci, N. Pasquariello, N. Battista, M. Di Tommaso, C. Rapino, F. Fezza, M. Zuccolo, R. Jourdain, A. Finazzi Agro, L. Breton, et al. (2012)
J. Biol. Chem. 287, 15466-15478
   Abstract »    Full Text »    PDF »
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling.
J. Palazuelos, Z. Ortega, J. Diaz-Alonso, M. Guzman, and I. Galve-Roperh (2012)
J. Biol. Chem. 287, 1198-1209
   Abstract »    Full Text »    PDF »
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum.
P. Zhong, B. Pan, X.-p. Gao, J. L. Blankman, B. F. Cravatt, and Q.-s. Liu (2011)
J. Physiol. 589, 4847-4855
   Abstract »    Full Text »    PDF »
Alterations of Endocannabinoid Signaling, Synaptic Plasticity, Learning, and Memory in Monoacylglycerol Lipase Knock-out Mice.
B. Pan, W. Wang, P. Zhong, J. L. Blankman, B. F. Cravatt, and Q.-s. Liu (2011)
J. Neurosci. 31, 13420-13430
   Abstract »    Full Text »    PDF »
Activation of Cannabinoid Type 2 Receptors Inhibits HIV-1 Envelope Glycoprotein gp120-Induced Synapse Loss.
H. J. Kim, A. H. Shin, and S. A. Thayer (2011)
Mol. Pharmacol. 80, 357-366
   Abstract »    Full Text »    PDF »
Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
M. E. Hofmann, C. Bhatia, and C. J. Frazier (2011)
J. Physiol. 589, 3801-3821
   Abstract »    Full Text »    PDF »
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging.
O. Albayram, J. Alferink, J. Pitsch, A. Piyanova, K. Neitzert, K. Poppensieker, D. Mauer, K. Michel, A. Legler, A. Becker, et al. (2011)
PNAS 108, 11256-11261
   Abstract »    Full Text »    PDF »
Molecular and Morphological Configuration for 2-Arachidonoylglycerol-Mediated Retrograde Signaling at Mossy Cell-Granule Cell Synapses in the Dentate Gyrus.
M. Uchigashima, M. Yamazaki, M. Yamasaki, A. Tanimura, K. Sakimura, M. Kano, and M. Watanabe (2011)
J. Neurosci. 31, 7700-7714
   Abstract »    Full Text »    PDF »
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis.
K. Goffin, W. Van Paesschen, and K. Van Laere (2011)
Brain 134, 1033-1040
   Abstract »    Full Text »    PDF »
Pharmacological Activation of Kainate Receptors Drives Endocannabinoid Mobilization.
J. Lourenco, I. Matias, G. Marsicano, and C. Mulle (2011)
J. Neurosci. 31, 3243-3248
   Abstract »    Full Text »    PDF »
Presynaptic CB1 Receptors Regulate Synaptic Plasticity at Cerebellar Parallel Fiber Synapses.
M. R. Carey, M. H. Myoga, K. R. McDaniels, G. Marsicano, B. Lutz, K. Mackie, and W. G. Regehr (2011)
J Neurophysiol 105, 958-963
   Abstract »    Full Text »    PDF »
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
C. Blazquez, A. Chiarlone, O. Sagredo, T. Aguado, M. R. Pazos, E. Resel, J. Palazuelos, B. Julien, M. Salazar, C. Borner, et al. (2011)
Brain 134, 119-136
   Abstract »    Full Text »    PDF »
Endocannabinoids Prevent {beta}-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons.
J. Noonan, R. Tanveer, A. Klompas, A. Gowran, J. McKiernan, and V. A. Campbell (2010)
J. Biol. Chem. 285, 38543-38554
   Abstract »    Full Text »    PDF »
Effects of a Commonly Occurring Genetic Polymorphism of Human CYP3A4 (I118V) on the Metabolism of Anandamide.
M. Pratt-Hyatt, H. Zhang, N. T. Snider, and P. F. Hollenberg (2010)
Drug Metab. Dispos. 38, 2075-2082
   Abstract »    Full Text »    PDF »
BDNF Evokes Release of Endogenous Cannabinoids at Layer 2/3 Inhibitory Synapses in the Neocortex.
F. Lemtiri-Chlieh and E. S. Levine (2010)
J Neurophysiol 104, 1923-1932
   Abstract »    Full Text »    PDF »
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo.
K. Van Laere, C. Casteels, I. Dhollander, K. Goffin, I. Grachev, G. Bormans, and W. Vandenberghe (2010)
J. Nucl. Med. 51, 1413-1417
   Abstract »    Full Text »    PDF »
The Role of Endocannabinoid Signaling in Motor Control.
A. El Manira and A. Kyriakatos (2010)
Physiology 25, 230-238
   Abstract »    Full Text »    PDF »
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease.
C. Zuccato, M. Valenza, and E. Cattaneo (2010)
Physiol Rev 90, 905-981
   Abstract »    Full Text »    PDF »
Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-{gamma}.
B. Mukhopadhyay, J. Liu, D. Osei-Hyiaman, G. Godlewski, P. Mukhopadhyay, L. Wang, W.-I. Jeong, B. Gao, G. Duester, K. Mackie, et al. (2010)
J. Biol. Chem. 285, 19002-19011
   Abstract »    Full Text »    PDF »
Distinct Endocannabinoid Control of GABA Release at Perisomatic and Dendritic Synapses in the Hippocampus.
S.-H. Lee, C. Foldy, and I. Soltesz (2010)
J. Neurosci. 30, 7993-8000
   Abstract »    Full Text »    PDF »
Homer 1a Gates the Induction Mechanism for Endocannabinoid-Mediated Synaptic Plasticity.
A. M. Roloff, G. R. Anderson, K. A. Martemyanov, and S. A. Thayer (2010)
J. Neurosci. 30, 3072-3081
   Abstract »    Full Text »    PDF »
Pretreatment With Electroacupuncture Induces Rapid Tolerance to Focal Cerebral Ischemia Through Regulation of Endocannabinoid System.
Q. Wang, Y. Peng, S. Chen, X. Gou, B. Hu, J. Du, Y. Lu, and L. Xiong (2009)
Stroke 40, 2157-2164
   Abstract »    Full Text »    PDF »
Endocannabinoid-Mediated Control of Synaptic Transmission.
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe (2009)
Physiol Rev 89, 309-380
   Abstract »    Full Text »    PDF »
Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3'-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats.
M. Scherma, L. V. Panlilio, P. Fadda, L. Fattore, I. Gamaleddin, B. Le Foll, Z. Justinova, E. Mikics, J. Haller, J. Medalie, et al. (2008)
J. Pharmacol. Exp. Ther. 327, 482-490
   Abstract »    Full Text »    PDF »
N-arachidonylethanolamide-Induced Increase in Aqueous Humor Outflow Facility.
Y. F. Njie, Z. Qiao, Z. Xiao, W. Wang, and Z.-H. Song (2008)
Invest. Ophthalmol. Vis. Sci. 49, 4528-4534
   Abstract »    Full Text »    PDF »
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation.
J. Zhang and C. Chen (2008)
J. Biol. Chem. 283, 22601-22611
   Abstract »    Full Text »    PDF »
Cannabinoids Inhibit Network-Driven Synapse Loss between Hippocampal Neurons in Culture.
H. J. Kim, J. J. Waataja, and S. A. Thayer (2008)
J. Pharmacol. Exp. Ther. 325, 850-858
   Abstract »    Full Text »    PDF »
Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries.
E. M. Awumey, S. K. Hill, D. I. Diz, and R. D. Bukoski (2008)
Am J Physiol Heart Circ Physiol 294, H2363-H2370
   Abstract »    Full Text »    PDF »
Dendritic Excitability and Synaptic Plasticity.
P. J. Sjostrom, E. A. Rancz, A. Roth, and M. Hausser (2008)
Physiol Rev 88, 769-840
   Abstract »    Full Text »    PDF »
Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus.
A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona (2008)
J. Neurosci. 28, 2976-2990
   Abstract »    Full Text »    PDF »
Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala.
S. C. Azad, J. Kurz, G. Marsicano, B. Lutz, W. Zieglgansberger, and G. Rammes (2008)
Learn. Mem. 15, 143-152
   Abstract »    Full Text »    PDF »
Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects.
K. Van Laere, M. Koole, S. M. Sanabria Bohorquez, K. Goffin, I. Guenther, M. J. Belanger, J. Cote, P. Rothenberg, I. De Lepeleire, I. D. Grachev, et al. (2008)
J. Nucl. Med. 49, 439-445
   Abstract »    Full Text »    PDF »
CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a.
J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al. (2007)
Mol. Pharmacol. 72, 1557-1566
   Abstract »    Full Text »    PDF »
Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage.
D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr (2007)
J. Pharmacol. Exp. Ther. 322, 1059-1066
   Abstract »    Full Text »    PDF »
The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis.
T. Aguado, E. Romero, K. Monory, J. Palazuelos, M. Sendtner, G. Marsicano, B. Lutz, M. Guzman, and I. Galve-Roperh (2007)
J. Biol. Chem. 282, 23892-23898
   Abstract »    Full Text »    PDF »
Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure-Induced Ischemia in Rats.
C. Nucci, V. Gasperi, R. Tartaglione, A. Cerulli, A. Terrinoni, M. Bari, C. De Simone, A. F. Agro, L. A. Morrone, M. T. Corasaniti, et al. (2007)
Invest. Ophthalmol. Vis. Sci. 48, 2997-3004
   Abstract »    Full Text »    PDF »
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants.
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault (2007)
J. Neurosci. 27, 6937-6947
   Abstract »    Full Text »    PDF »
The Endocannabinoid System and Neurogenesis in Health and Disease.
I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzman (2007)
Neuroscientist 13, 109-114
   Abstract »    PDF »
Functional CB1 Receptors Are Broadly Expressed in Neocortical GABAergic and Glutamatergic Neurons.
E. L. Hill, T. Gallopin, I. Ferezou, B. Cauli, J. Rossier, P. Schweitzer, and B. Lambolez (2007)
J Neurophysiol 97, 2580-2589
   Abstract »    Full Text »    PDF »
Anandamide Protects from Low Serum-induced Apoptosis via Its Degradation to Ethanolamine.
D. Matas, A. Juknat, M. Pietr, Y. Klin, and Z. Vogel (2007)
J. Biol. Chem. 282, 7885-7892
   Abstract »    Full Text »    PDF »
Opposing Modifications in Intrinsic Currents and Synaptic Inputs in Post-Traumatic Mossy Cells: Evidence for Single-Cell Homeostasis in a Hyperexcitable Network.
A. L. Howard, A. Neu, R. J. Morgan, J. C. Echegoyen, and I. Soltesz (2007)
J Neurophysiol 97, 2394-2409
   Abstract »    Full Text »    PDF »
Oxyhomologation of the Amide Bond Potentiates Neuroprotective Effects of the Endolipid N-Palmitoylethanolamine.
G. Lombardi, G. Miglio, F. Varsaldi, A. Minassi, and G. Appendino (2007)
J. Pharmacol. Exp. Ther. 320, 599-606
   Abstract »    Full Text »    PDF »
Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures.
K. Chen, A. Neu, A. L. Howard, C. Foldy, J. Echegoyen, L. Hilgenberg, M. Smith, K. Mackie, and I. Soltesz (2007)
J. Neurosci. 27, 46-58
   Abstract »    Full Text »    PDF »
Differential Effects of Endocannabinoids on Glutamatergic and GABAergic Inputs to Layer 5 Pyramidal Neurons.
D. A. Fortin and E. S. Levine (2007)
Cereb Cortex 17, 163-174
   Abstract »    Full Text »    PDF »
Lipid Signaling and Synaptic Plasticity.
N. Sang and C. Chen (2006)
Neuroscientist 12, 425-434
   Abstract »    PDF »
CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action.
A. Degroot, A. Kofalvi, M. R. Wade, R. J. Davis, R. J. Rodrigues, N. Rebola, R. A. Cunha, and G. G. Nomikos (2006)
Mol. Pharmacol. 70, 1236-1245
   Abstract »    Full Text »    PDF »
Induction of Krox-24 by Endogenous Cannabinoid Type 1 Receptors in Neuro2A Cells Is Mediated by the MEK-ERK MAPK Pathway and Is Suppressed by the Phosphatidylinositol 3-Kinase Pathway.
E. S. Graham, N. Ball, E. L. Scotter, P. Narayan, M. Dragunow, and M. Glass (2006)
J. Biol. Chem. 281, 29085-29095
   Abstract »    Full Text »    PDF »
The Endocannabinoid System as an Emerging Target of Pharmacotherapy.
P. Pacher, S. Batkai, and G. Kunos (2006)
Pharmacol. Rev. 58, 389-462
   Abstract »    Full Text »    PDF »
Forebrain-Specific Inactivation of Gq/G11 Family G Proteins Results in Age-Dependent Epilepsy and Impaired Endocannabinoid Formation.
N. Wettschureck, M. van der Stelt, H. Tsubokawa, H. Krestel, A. Moers, S. Petrosino, G. Schutz, V. Di Marzo, and S. Offermanns (2006)
Mol. Cell. Biol. 26, 5888-5894
   Abstract »    Full Text »    PDF »
Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes..
K. Kamprath, G. Marsicano, J. Tang, K. Monory, T. Bisogno, V. D. Marzo, B. Lutz, and C. T. Wotjak (2006)
J. Neurosci. 26, 6677-6686
   Abstract »    Full Text »    PDF »
Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus.
R. E. Blair, L. S. Deshpande, S. Sombati, K. W. Falenski, B. R. Martin, and R. J. DeLorenzo (2006)
J. Pharmacol. Exp. Ther. 317, 1072-1078
   Abstract »    Full Text »    PDF »
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses.
I. Katona, G. M. Urban, M. Wallace, C. Ledent, K.-M. Jung, D. Piomelli, K. Mackie, and T. F. Freund (2006)
J. Neurosci. 26, 5628-5637
   Abstract »    Full Text »    PDF »
Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic Transmission.
M. R. Domenici, S. C. Azad, G. Marsicano, A. Schierloh, C. T. Wotjak, H.-U. Dodt, W. Zieglgansberger, B. Lutz, and G. Rammes (2006)
J. Neurosci. 26, 5794-5799
   Abstract »    Full Text »    PDF »
Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice.
L. G. Bilsland, J. R. T. Dick, G. Pryce, S. Petrosino, V. Di Marzo, D. Baker, and L. Greensmith (2006)
FASEB J 20, 1003-1005
   Abstract »    Full Text »    PDF »
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection.
A. Witting, L. Chen, E. Cudaback, A. Straiker, L. Walter, B. Rickman, T. Moller, C. Brosnan, and N. Stella (2006)
PNAS 103, 6362-6367
   Abstract »    Full Text »    PDF »
Fatty Acid Amide Hydrolase (-/-) Mice Exhibit an Increased Sensitivity to the Disruptive Effects of Anandamide or Oleamide in a Working Memory Water Maze Task.
S. A. Varvel, B. F. Cravatt, A. E. Engram, and A. H. Lichtman (2006)
J. Pharmacol. Exp. Ther. 317, 251-257
   Abstract »    Full Text »    PDF »
Elevation of Endocannabinoid Levels in the Ventrolateral Periaqueductal Grey through Inhibition of Fatty Acid Amide Hydrolase Affects Descending Nociceptive Pathways via Both Cannabinoid Receptor Type 1 and Transient Receptor Potential Vanilloid Type-1 Receptors.
S. Maione, T. Bisogno, V. de Novellis, E. Palazzo, L. Cristino, M. Valenti, S. Petrosino, V. Guglielmotti, F. Rossi, and V. D. Marzo (2006)
J. Pharmacol. Exp. Ther. 316, 969-982
   Abstract »    Full Text »    PDF »
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity.
S. H. Kim, S. J. Won, X. O. Mao, K. Jin, and D. A. Greenberg (2006)
Mol. Pharmacol. 69, 691-696
   Abstract »    Full Text »    PDF »
The Endocannabinoid System Promotes Astroglial Differentiation by Acting on Neural Progenitor Cells.
T. Aguado, J. Palazuelos, K. Monory, N. Stella, B. Cravatt, B. Lutz, G. Marsicano, Z. Kokaia, M. Guzman, and I. Galve-Roperh (2006)
J. Neurosci. 26, 1551-1561
   Abstract »    Full Text »    PDF »
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones.
A. Straiker and K. Mackie (2005)
J. Physiol. 569, 501-517
   Abstract »    Full Text »    PDF »
Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors.
M. D. Van Sickle, M. Duncan, P. J. Kingsley, A. Mouihate, P. Urbani, K. Mackie, N. Stella, A. Makriyannis, D. Piomelli, J. S. Davison, et al. (2005)
Science 310, 329-332
   Abstract »    Full Text »    PDF »
Dual Modulation of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Protects against Excitotoxicity.
D. A. Karanian, Q. B. Brown, A. Makriyannis, T. A. Kosten, and B. A. Bahr (2005)
J. Neurosci. 25, 7813-7820
   Abstract »    Full Text »    PDF »
Altering cannabinoid signaling during development disrupts neuronal activity.
C. Bernard, M. Milh, Y. M. Morozov, Y. Ben-Ari, T. F. Freund, and H. Gozlan (2005)
PNAS 102, 9388-9393
   Abstract »    Full Text »    PDF »
Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation.
B. G. Ramirez, C. Blazquez, T. G. del Pulgar, M. Guzman, and M. L. de Ceballos (2005)
J. Neurosci. 25, 1904-1913
   Abstract »    Full Text »    PDF »
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY.
F. RODRIGUEZ de FONSECA, I. DEL ARCO, F. J. BERMUDEZ-SILVA, A. BILBAO, A. CIPPITELLI, and M. NAVARRO (2005)
Alcohol Alcohol. 40, 2-14
   Abstract »    Full Text »    PDF »
Endocannabinoids Link Feeding State and Auditory Perception-Related Gene Expression.
K. Soderstrom, Q. Tian, M. Valenti, and V. Di Marzo (2004)
J. Neurosci. 24, 10013-10021
   Abstract »    Full Text »    PDF »
ATP Induces a Rapid and Pronounced Increase in 2-Arachidonoylglycerol Production by Astrocytes, a Response Limited by Monoacylglycerol Lipase.
L. Walter, T. Dinh, and N. Stella (2004)
J. Neurosci. 24, 8068-8074
   Abstract »    Full Text »    PDF »
CB1 Cannabinoid Receptors Modulate Kinase and Phosphatase Activity During Extinction of Conditioned Fear in Mice.
A. Cannich, C. T. Wotjak, K. Kamprath, H. Hermann, B. Lutz, and G. Marsicano (2004)
Learn. Mem. 11, 625-632
   Abstract »    Full Text »    PDF »
The Neuroscientist Comments.
(2004)
Neuroscientist 10, 89-90
   PDF »
P2X7 receptors control 2-arachidonoylglycerol production by microglial cells.
A. Witting, L. Walter, J. Wacker, T. Moller, and N. Stella (2004)
PNAS 101, 3214-3219
   Abstract »    Full Text »    PDF »
NEUROSCIENCE: Stout Guards of the Central Nervous System.
R. Mechoulam and A. H. Lichtman (2003)
Science 302, 65-67
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882